iShares MSCI Europe SRI UCITS ETF

What this fund is

iShares MSCI Europe SRI UCITS ETF is an exchange-traded fund (ETF) from iShares, traded under the ticker CBUD (ISIN IE000CR424L6). It lets you buy a basket of holdings in a single trade, spreading your money across them rather than one company. In plain terms it is about owning small slices of companies, so you share in their growth when they do well — and their falls when they don't, focused on the European market. Rather than a manager picking stocks, it simply replicates the MSCI Europe index — the passive, low-cost approach, and its largest holdings include ASML HOLDING NV, NOVARTIS AG and SCHNEIDER ELECTRIC. It holds around 137 positions (the ten largest ≈ 37%), spreading risk so no single holding decides your outcome.

Geographically it leans ~22.5% Switzerland, ~18.2% France and ~16.5% Netherlands. Its heaviest sectors are ~24.9% Financials and ~20.6% Industrials. Funds like this are commonly chosen by investors who want a regular cash income stream rather than reinvesting everything for growth. Its ongoing charge (TER) is 0.23% a year — about €23 a year on a €10,000 holding, taken automatically from the fund. Income such as dividends is paid out to you as cash (a distributing share class), and over the last year it paid out roughly 1.7% (its trailing yield).

It holds the underlying investments directly (physical replication); it is domiciled in Ireland and UCITS-regulated, a European standard built to protect everyday investors and trades in EUR. Its price has swung about 13.5% over the past year, which describes how much its price tends to move rather than whether it is good. It launched in 2021. As with any investment, its value can go down as well as up, and past performance is not a guide to future results. (Fund data sourced from iShares.)